Journal of the American Society of Nephrology
2008 JASN IMPACT FACTOR 7.505 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on December 3, 2009
J Am Soc Nephrol 21: 237-248, 2010
© 2010 American Society of Nephrology
doi: 10.1681/ASN.2009050462

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2009050462v1
21/2/237    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Ardura, J. A.
Right arrow Articles by Esbrit, P.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ardura, J. A.
Right arrow Articles by Esbrit, P.

BASIC RESEARCH

Parathyroid Hormone–Related Protein Promotes Epithelial–Mesenchymal Transition

Juan Antonio Ardura*, Sandra Rayego-Mateos{dagger}, David Rámila*, Marta Ruiz-Ortega{dagger} and Pedro Esbrit*

*Bone and Mineral Metabolism Laboratory and
{dagger}Cellular Biology in Renal Diseases Laboratory, Fundación Jiménez Díaz (Capio Group) and Universidad Autónoma de Madrid, Madrid, Spain

Correspondence: Dr. Pedro Esbrit, Laboratorio de Metabolismo Mineral y Óseo, Fundación Jiménez Díaz-UTE, Avda. Reyes Católicos 2, 28040 Madrid, Spain. Phone: 34-91-550-4894; Fax: 34-91-549-8075; E-mail: pesbrit{at}fjd.es

Received for publication May 1, 2009. Accepted for publication October 4, 2009.

Epithelial–mesenchymal transition (EMT) is an important process that contributes to renal fibrogenesis. TGF-β1 and EGF stimulate EMT. Recent studies suggested that parathyroid hormone–related protein (PTHrP) promotes fibrogenesis in the damaged kidney, apparently dependent on its interaction with vascular endothelial growth factor (VEGF), but whether it also interacts with TGF-β and EGF to modulate EMT is unknown. Here, PTHrP(1-36) increased TGF-β1 in cultured tubuloepithelial cells and TGF-β blockade inhibited PTHrP-induced EMT-related changes, including upregulation of {alpha}-smooth muscle actin and integrin-linked kinase, nuclear translocation of Snail, and downregulation of E-cadherin and zonula occludens-1. PTHrP(1-36) also induced EGF receptor (EGFR) activation; inhibition of protein kinase C and metalloproteases abrogated this activation. Inhibition of EGFR activation abolished these EMT-related changes, the activation of ERK1/2, and upregulation of TGF-β1 and VEGF by PTHrP(1-36). Moreover, inhibition of ERK1/2 blocked EMT induced by either PTHrP(1-36), TGF-β1, EGF, or VEGF. In vivo, obstruction of mouse kidneys led to changes consistent with EMT and upregulation of TGF-β1 mRNA, p-EGFR protein, and PTHrP. Taken together, these data suggest that PTHrP, TGF-β, EGF, and VEGF might cooperate through activation of ERK1/2 to induce EMT in renal tubuloepithelial cells.







HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP